Search results
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
CNBC· 4 hours agoA panel of independent advisors to the Food and Drug Administration on Monday recommended Eli Lilly'...
FDA panel backs Eli Lilly’s Alzheimer’s drug
The Hill· 1 hour agoA federal advisory panel on Monday voted in favor of recommending Eli Lilly’s new drug that is under consideration for its potential to slow the...
Lilly Alzheimer’s drug gets unanimous backing of FDA panel
BioPharma Dive via Yahoo Finance· 8 hours agoARIA is quite often asymptomatic and is only identified via magnetic resonance imaging But at least...
Alzheimer’s drug from Eli Lilly wins backing of FDA committee
Washington Post· 3 hours agoMuch of the committee’s discussion focused on the safety of the drug, donanemab, which works by...
Lilly's Alzheimer's drug faces delayed reckoning
Axios· 12 hours agoThe outlook for the latest experimental drug shown to delay Alzheimer's disease will come into focus Monday, when Food and Drug Administration ...
Alzheimer’s drug that can slow disease gets backing from FDA advisers
WYMT Eastern Kentucky· 3 hours agoA closely watched Alzheimer’s drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment’s< ...
FDA advisors strongly back new Alzheimer’s drug, despite risks and limitations
NPR· 1 hour agoThe older drug is given every two weeks indefinitely, while the newer one is given monthly and could be stopped...Donanemab, which targets the amyloid plaques that build up ...
New Alzheimer’s treatment drug gets support from FDA advisory panel
WXYZ-TV Detroit· 3 hours agoIf approved by the FDA, it would become the second Alzheimer’s drug on the market. Alzheimer’s is an incurable disease that affects nearly ...
FDA panel approves Alzheimer's drug that can slow disease
First Coast News· 3 hours agoA closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers on...